Idexx Laboratories (IDXX) reported $1.09 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 14.3%. EPS of $3.08 for the same period compares to $2.62 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.07 billion, representing a surprise of +1.86%. The company delivered an EPS surprise of +5.17%, with the consensus EPS estimate being $2.93.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Idexx performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Percent of Revenue- Gross Profit - CAG: 60.5% versus the two-analyst average estimate of 60.2%.
- Percent of Revenue- Gross Profit - Other: 29.4% compared to the 29.8% average estimate based on two analysts.
- Percent of Revenue- Gross Profit - LPD: 50.6% versus 50.1% estimated by two analysts on average.
- Percent of Revenue- Gross Profit - Water: 66.6% versus the two-analyst average estimate of 71.7%.
- Revenue- Companion Animal Group(CAG)- United States: $642.66 million compared to the $637.61 million average estimate based on two analysts. The reported number represents a change of +11.9% year over year.
- Revenue- Companion Animal Group(CAG)- International: $355.82 million versus the two-analyst average estimate of $344.39 million. The reported number represents a year-over-year change of +20.1%.
- Revenue- LPD- International: $30.45 million versus the two-analyst average estimate of $31.74 million. The reported number represents a year-over-year change of +8.2%.
- Revenue- Water- International: $26.88 million compared to the $25.82 million average estimate based on two analysts. The reported number represents a change of +16.2% year over year.
- Revenue- Companion Animal Group (CAG): $998.47 million versus the five-analyst average estimate of $981.34 million. The reported number represents a year-over-year change of +14.7%.
- Revenue- Other: $4.09 million versus $4.19 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -0.4% change.
- Revenue- Livestock and poultry diagnostics (LPD): $37.49 million compared to the $37.26 million average estimate based on five analysts. The reported number represents a change of +8.5% year over year.
- Revenue- Water: $50.53 million compared to the $48.65 million average estimate based on five analysts. The reported number represents a change of +11.9% year over year.
View all Key Company Metrics for Idexx here>>>
Shares of Idexx have returned +0.1% over the past month versus the Zacks S&P 500 composite's +0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
IDEXX Laboratories, Inc. (IDXX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
